XML 12 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 21,236 $ 21,293
General and administrative 6,451 8,477
Total operating expenses 27,687 29,770
Loss from operations (27,687) (29,770)
Grant income   157
Other income, net 1,350 1,793
Net loss (26,337) (27,820)
Unrealized gain on available-for-sale securities 212 927
Comprehensive loss attributable to common stockholders $ (26,125) $ (26,893)
Net loss per share attributable to common stockholders, basic $ (0.69) $ (0.73)
Net loss per share attributable to common stockholders, diluted $ (0.69) $ (0.73)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic 38,321,573 37,923,402
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted 38,321,573 37,923,402